The Middle East & Africa percutaneous mechanical circulatory support devices market is expected to reach US$ 203.79 million by 2027 from US$ 81.34 million in 2019; it is estimated to grow at a CAGR of 12.5% from 2020 to 2027.
The rising geriatric population, and increasing prevalence of cardiovascular diseases are the key factors driving the growth of percutaneous mechanical circulatory support devices. However, high costs of these devices and procedures associated with them, and impact of COVID-19 pandemic on medical device industry is the major factor hindering the Percutaneous mechanical circulatory support devices market growth in Middle East & Africa.
Percutaneous mechanical circulatory support devices offer an effective and rapid approach to slow the downward spiral of hemodynamic instability among patients suffering with decompensated heart failures and cardiogenic shocks till a more definitive strategy is perceived among patients to recover from these cardiac ailments. The major roles of the percutaneous mechanical circulatory support devices include improving the native cardiac output, reducing ventricular volume and filling pressures, augmenting coronary perfusion, and maintaining vital organ perfusion.
Improvements in the surgical techniques coupled with quality of implantable valves have led to substantial growth in the volume of valve replacement procedures performed. The rising prevalence of these surgeries helps to save more lives and subsequently provide better quality of health and life to the patients suffering from congenital heart diseases (CHDs). Various Middle East & Africa countries are offering medical reimbursements for medical procedures involving valve replacement. Improvements in health care policies, with reimbursement policies for the population have ensured an increased life expectancy. Thus, the increasing reimbursement for these procedures is likely to increase their volumes and be a prevalent trend in the market during the forecast period.
The healthcare infrastructure in large cities of developing countries may have all the necessary amenities, but rural areas may not. Thus, these massive unexplored areas pose as ample revenue generation opportunities for percutaneous mechanical circulatory support devices market, as cardiovascular diseases are among the prominently prevalent health conditions within these economies. Countries like UAE and Saudi Arabia have a large patient population base, and the healthcare expenditure is increasing, thus illustrating immense healthcare market potential. Thus, with the growing healthcare industry and increasing government initiatives, the demand for percutaneous mechanical circulatory support devices is expected to increase in the developing economies.
COVID-19 pandemic is making its way to all Middle East & Africa countries. Due to growing COVID-19, these countries are expecting to witness a huge challenge and are expected to affect largely to healthcare industries in the current situation. In Saudi Arabia, it has been reported that the confirmed cases has been increased to 21,400 and death rate has been low with 160 numbers. These numbers are changing owing to various factors such as the prevalence of chronic disease patients, surgeries, population density in regions, and other factors. Restrictive measures have been taken to control the spread of this pandemic. Moreover, due to surgeries, the number of COVID-19 numbers is also growing. This pandemic is affecting the business operation of the various key players operating in this region.
Rest of Middle East & Africa Percutaneous Mechanical Circulatory Support Devices Market, Revenue and Forecast to 2027 (US$ Mn)
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
MIDDLE EAST & AFRICA PERCUTANEOUS MECHANICAL CIRCULATORY SUPPORT DEVICES MARKET SEGMENTATION
By Product
- Intra-Aortic Balloon Pumps
- VA-Extracorporeal Membrane Oxygenation (ECMO)
- Short-Term Ventricular Assist Devices (VADs)
- Impella
- Tandem Heart
By End User
- Hospitals
- Ambulatory Surgical Centers
- Others
By Country
- UAE
- Saudi Arabia
- South Africa
Company Profiles
- Abbott
- Livanova Plc (Cardiacassist, Inc)
- Eurosets
- Berlin Heart
- Medtronic
Middle East and Africa Percutaneous Mechanical Circulatory Support Devices Report Scope
Report Attribute | Details |
---|---|
Market size in 2019 | US$ 81.34 Million |
Market Size by 2027 | US$ 203.79 Million |
Global CAGR (2020 - 2027) | 12.5% |
Historical Data | 2017-2018 |
Forecast period | 2020-2027 |
Segments Covered |
By Product
|
Regions and Countries Covered | Middle East and Africa
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Recent Reports
Testimonials
Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends

















